Fig. 4From: A cost-effectiveness analysis of capecitabine maintenance therapy versus routine follow-up for early-stage triple-negative breast cancer patients after standard treatment from a perspective of Chinese societyMarkov model structure. A Model states and transitions. B Schematic of decision tree and Markov model. DFS, disease-free survival; TNBC, triple-negative breast cancerBack to article page